10108 Federal Register / Vol. 86, No. 31 / Thursday, February 18, 2021 / Notices 

website at http://www.samhsa.gov/ 

about-us/advisory-councils/csatnational-advisory-council or by 

contacting the CSAT National Advisory 

Council Designated Federal Officer. 

Council Name: SAMHSA’s Center for 

Substance Abuse Treatment, National 

Advisory Council. 

Date/Time/Type: March 31, 2021, 

1:00 p.m.–6:00 p.m. EDT, OPEN. 

Place: SAMHSA, 5600 Fishers Lane, 

Rockville, Maryland 20857. 

Contact: Tracy Goss, Designated 

Federal Officer, CSAT National 

Advisory Council, 5600 Fishers Lane, 

Rockville, Maryland 20857 (mail), 

Telephone: (240) 276–0759, Email: 

tracy.goss@samhsa.hhs.gov. 

Dated: February 11, 2021. 

Carlos Castillo, 

Committee Management Officer, SAMHSA. 

[FR Doc. 2021–03269 Filed 2–17–21; 8:45 am] 

BILLING CODE 4162–20–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2019–N–0803] 

Advisory Committee; Technical 

Electronic Product Radiation Safety 

Standards Committee; Renewal 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice; renewal of Federal 

advisory committee. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing the 

renewal of the Technical Electronic 

Product Radiation Safety Standards 

Committee by the Commissioner of 

Food and Drugs (the Commissioner). 

The Commissioner has determined that 

it is in the public interest to renew the 

Technical Electronic Product Radiation 

Safety Standards Committee for an 

additional 2 years beyond the charter 

expiration date. The new charter will be 

in effect until the December 24, 2022, 

expiration date. 

DATES: Authority for the Technical 

Electronic Product Radiation Safety 

Standards Committee (the Committee) 

will expire on December 24, 2022, 

unless the Commissioner formally 

determines that renewal is in the public 

interest. 

FOR FURTHER INFORMATION CONTACT: 

Patricio Garcia, Center for Devices and 

Radiological Health, Food and Drug 

Administration, 10903 New Hampshire 

Ave., Bldg. 66, Rm. 5216, Silver Spring, 

MD 20993–0002, 301–796–6875, email: 

Patricio.Garcia@fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: Pursuant 

to 41 CFR 102–3.65 and approval by the 

Department of Health and Human 

Services pursuant to 45 CFR part 11 and 

by the General Services Administration, 

FDA is announcing the renewal of the 

Committee. The Committee is a nondiscretionary Federal advisory 

committee established to provide advice 

to the Commissioner. 

The Commissioner is charged with 

the administration of the Radiation 

Control for Health and Safety Act of 

1968. This Act creates the Committee 

and requires the Commissioner to 

consult with the Committee before 

prescribing standards for radiation 

emissions from electronic products. 

This Committee provides advice and 

consultation to the Commissioner on the 

technical feasibility, reasonableness, 

and practicability of performance 

standards for electronic products to 

control the emission of radiation from 

such products and may recommend 

electronic product radiation safety 

standards to the Commissioner for 

consideration. 

The Committee shall consist of 15 

voting members, including the Chair. 

Members and the Chair are selected by 

the Commissioner or designee from 

among authorities knowledgeable in the 

fields of science or engineering 

applicable to electronic product 

radiation safety. Members will be 

invited to serve for overlapping terms of 

up to 4 years. Voting members will 

include five members selected from 

governmental agencies, including State 

and Federal Governments, five members 

from the affected industries, and five 

members from the general public, of 

which at least one shall be a 

representative of organized labor. A 

quorum shall consist of 10 members, of 

which at least 3 shall be from the 

general public, 3 from the government 

agencies, and 3 from the affected 

industries. 

Further information regarding the 

most recent charter and other 

information can be found at https://

www.fda.gov/AdvisoryCommittees/ 

CommitteesMeetingMaterials/RadiationEmittingProducts/ 

TechnicalElectronicProduct

RadiationSafetyStandardsCommittee/ 

default.htm or by contacting the 

Designated Federal Officer (see FOR

FURTHER INFORMATION CONTACT). In light 

of the fact that no change has been made 

to the committee name or description of 

duties, no amendment will be made to 

21 CFR 14.100. 

This notice is issued under the 

Federal Advisory Committee Act (5 

U.S.C. app.). For general information 

related to FDA advisory committees, 

please visit us at https://www.fda.gov/ 

AdvisoryCommittees/default.htm. 

Dated: February 11, 2021. 

Lauren K. Roth, 

Acting Principal Associate Commissioner for 

Policy. 

[FR Doc. 2021–03239 Filed 2–17–21; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2012–N–0115] 

Agency Information Collection 

Activities; Proposed Collection; 

Comment Request; Guidance for 

Industry and Food and Drug 

Administration Staff—Class II Special 

Controls Guidance Document: 

Automated Blood Cell Separator 

Device Operating by Centrifugal or 

Filtration Principle 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA or Agency) is 

announcing an opportunity for public 

comment on the proposed collection of 

certain information by the Agency. 

Under the Paperwork Reduction Act of 

1995 (PRA), Federal Agencies are 

required to publish notice in the 

Federal Register concerning each 

proposed collection of information, 

including each proposed extension of an 

existing collection of information, and 

to allow 60 days for public comment in 

response to the notice. This notice 

solicits comments on the collection of 

information concerning class II special 

controls for an automated blood cell 

separator device operating by 

centrifugal or filtration separation 

principle. 

DATES: Submit either electronic or 

written comments on the collection of 

information by April 19, 2021. 

ADDRESSES: You may submit comments 

as follows. Please note that late, 

untimely filed comments will not be 

considered. Electronic comments must 

be submitted on or before April 19, 

2021. The https://www.regulations.gov 

electronic filing system will accept 

comments until 11:59 p.m. Eastern Time 

at the end of April 19, 2021. Comments 

received by mail/hand delivery/courier 

(for written/paper submissions) will be 

considered timely if they are 

postmarked or the delivery service 

acceptance receipt is on or before that 

date. 


jbell on DSKJLSW7X2PROD with NOTICES